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Regulatedmovement of stem cells is critical for organogenesis during development and for homeo-
stasis and repair in adulthood. Here we analyze the biological significance and molecular mecha-
nisms underlying stem cell trafficking in the generation of the germline, and the generation and
regeneration of blood and muscle. Comparison across organisms and lineages reveals remarkable
conservation as well as specialization in homing andmigration mechanisms used by mature leuko-
cytes, adult and fetal stem cells, and cancer stem cells. In vivo trafficking underpins the successful
therapeutic application of hematopoietic stem cells for bone-marrow transplant, and further eluci-
dation of homing and migration pathways in other systems will enable broader application of stem
cells for targeted cell therapy and drug delivery.Stem cells are unspecialized precursor cells that are uniquely
capable of both differentiation, to produce mature daughter cells
that carry out particular tissue functions, andself-renewal, to sus-
tain and replenish the stemcell pool. Stemcells play a critical role
in the establishment of embryonic tissues during development
and in some cases are retained into adulthood, where they sup-
port ongoing replacement of short-lived mature effector cells
as well as injury-induced regeneration of diseased or damaged
daughter cells. Regarding hematopoietic stem cells (HSCs), re-
cent evidence suggests that these cells may also participate di-
rectly in immune surveillance and defense against invading
pathogens (Massberg et al., 2007).
Implicit in the generative, regenerative, and immunological
functions of tissue-specific stem cells is the proper localization
of these precursors, which is essential to build organs and tis-
sues during development and to foster localized tissue defense
and repair after damage. New studies provide increasing sup-
port for the notion that stem cells in vivo require inputs from par-
ticular defined microenvironments, or ‘‘niches,’’ which support
their unique stem cell functions (see Review by S.J. Morrison
and A.C. Spradling, page 598 of this issue). Long-term mainte-
nance of stem cells, therefore, requires their migration to and en-
graftment within supportive stem cell niches.
Beyond the essential role of micro- and macroanatomical po-
sitioning in normal stem cell activity, it is becoming increasingly
clear that achieving targeted trafficking of stem cells will be
critical for effective tissue regeneration from transplanted cells
in the clinic. In addition, with the ability to manipulate stem cell
homing and migration, these cells become potential vectors for
in vivo delivery of therapeutic genes or drugs. Finally, with our612 Cell 132, 612–630, February 22, 2008 ª2008 Elsevier Inc.new view of many cancers as stem cell-maintained diseases of
dysregulated organogenesis (reviewed in Dalerba et al., 2007),
understanding the similarities and differences in the homing
and migration of malignant cancer stem cells, as compared to
their normal tissue counterparts, takes on new import for clarify-
ing the molecular events supporting tumor progression and
metastasis.
Here, we take a broad view of stem cell migration and homing
in normal development, tissue regeneration, and disease, to
identify conserved and distinct molecular mechanisms and bio-
logical themes governing the movement of stem cells in the
body. We focus on three different stem cell types—primordial
germ cells (PGCs), skeletal muscle satellite cells, and hemato-
poietic stem cells (HSCs)—and find new insights by comparing
their trafficking in the embryo and adult. This analysis is informed
by ground-breaking work in the cell-adhesion and -trafficking
fields, which over several decades have elucidated discrete
steps that support the homing and migration of immune and
stromal cell types in the body. Strikingly similar mechanisms ap-
pear to govern the in vivo migration of stem cells, arguing that
application of analogous principles to the analysis of stem cell
homing will uncover the key steps in this process and provide
new information that can be used therapeutically to target these
cells for regenerative medicine and anticancer therapy.
Migration and Homing
Stem cells in vivo participate in organogenesis, normal cell turn-
over, and repair from catastrophic injury. In each of these set-
tings, appropriate stem cell function often requires stem cell traf-
ficking, defined as the oriented or directed movement of a cell
towards a particular anatomic destination. For clarity, we distin-
guish in this review two principal modes of stem cell trafficking—
homing and interstitial migration.
Wedefinehomingasaprocesswherebystemcells aredissem-
inated throughout the body by the flowing blood until they recog-
nize and interact with microvascular endothelial cells in a partic-
ular target organ. Homing is best understood for HSCs, but this
processmay apply also to someother stemcell types—for exam-
ple, therapeutically infused mesenchymal stem cells (Pittenger
andMartin, 2004) andmetastasizing cancer stem cells (reviewed
in Balkwill, 2004; Burger and Kipps, 2006). The intravascular dis-
semination of homing stem cells is essentially passive, although
homing is always preceded and followed by an active migratory
phase during which cells must navigate the extravascular com-
partment to access the blood from their point of origin and to
reach their final destination in a distant target organ. A special
requirement of blood-borne stem cells is that they must have
the means to recognize tissue-specific microvascular features
in target organs, and once this recognition has occurred they
must adhere to the vessel wall with sufficient strength to over-
come the considerable shear stress exertedby the flowing blood.
The extravasation of blood-circulating stem cells into extravas-
cular tissues appears to invoke a multistep adhesion cascade
similar to that initially described in the homing of mature blood
leukocytes.
The second mode of trafficking, interstitial migration, requires
that stem cells recognize and obey extravascular guidance cues.
In contrast to homing, this mode of trafficking requires active
ameboid movement and can occur independent of blood flow.
The developmentally timed, trans-tissue migration of primordial
germ cells (PGCs) and of somite-derived skeletal muscle pre-
cursor cells are classic examples of interstitially migrating stem
cells.
Multistep Adhesion Cascades
Trafficking (migration) via homing appears to involve three (or
more) consecutive steps that rely on distinct receptor-ligand
pathways: (1) tethering and rolling, mediated by primary adhe-
sion molecules (selectins or a4-integrins) with fast binding kinet-
ics and high tensile strength but short bond lifetime; (2) a chemo-
tactic/activating stimulus provided by soluble or surface-bound
chemoattractants, which signal mostly through Gai-coupled
(i.e., pertussis toxin-sensitive) seven transmembrane domain
receptors; and (3) sticking mediated by secondary adhesion
molecules, mostly integrins (ß2 or a4) that interact with endothe-
lial ligands of the immunoglobulin superfamily (IgSF). These
sequential and molecularly distinct steps were originally defined
in early studies of the recruitment of circulating leukocytes from
blood to tissues, where each stage is characterized by distinct
biophysical requirements and the ordered involvement of dis-
cretemolecular entities (Springer, 1994). For example, neutrophil
extravasation (movement out of the blood and into the tissues) in
postcapillary venules of inflamed tissues requires first a selectin-
mediated step that allows flowing cells to marginate and roll
along the vessel wall. This rolling must be followed by a chemo-
attractant stimulus that induces rapid activation of ß2-integrins,
which mediate firm arrest (von Andrian et al., 1991). Genetic
defects in either selectin- or integrin-mediated adhesion steps
results in leukocyte-adhesion deficiency (LAD) syndrome andsevere recurrent bacterial infections. Multistep adhesion cas-
cades also operate during lymphocyte homing to lymph nodes
(LNs), Peyer’s patches, and other organs (von Andrian and
Mackay, 2000) and during seeding of the thymus by bone
marrow-derived lymphoid progenitors (Scimone et al., 2006).
A similar multistep adhesion cascade also mediates hematopoi-
etic stem and progenitor cell homing to mouse bone marrow
(BM), and the molecular effectors of this process are beginning
to be identified (Mazo et al., 1998, 2002).
Stem Cell Trafficking during Development
Stem cells comprise the building blocks of many tissues and
organs formed during embryogenesis. The specification and
morphogenesis of these tissues hinges upon proper localization
of stem cells or their precursors, which in many cases mandates
long-distance homing or interstitial migration in the embryo. Here
we compare the developmentally timed trafficking of three
distinct itinerant stem cells across multiple model organisms.
Stem cells of the germline and skeletal muscle, and a subset of
early HSCs, migrate interstitially through many different embry-
onic tissues. In contrast, late embryonic and fetal HSCs rely on
homing as a primary mode of dispersion throughout the body.
These comparisons reveal a striking conservation of stem cell
movement throughout evolution and a remarkable overlap in
the molecular effectors of interstitial migration and homing.
Germ Cells
The male and female gametes that carry genetic material to the
next generation arise from a transient stem cell population in the
embryo called primordial germ cells (PGCs). A small number of
these founders originate early in development, before distinct
germ layers or organs exist, and then traverse many different tis-
sues in the growing embryo while proliferating, presumably by
symmetric divisions (Anderson et al., 2000; Molyneaux et al.,
2001). After reaching the gonad primordia, bipotential PGCs un-
dergo genome-wide imprint erasure and commence sex-specfic
differentiation, which terminates in the production of oocytes or
spermatozoa during adult life (reviewed in McLaren, 2003). PGC
migration is essential to development of the germ lineage, as
evidenced by its ubiquity across multicellular organisms (see
below).
In the fruit fly Drosophila melanogaster, germ cells (referred to
as pole cells) are the first cells to be formed and are established
at the posterior pole of the embryo. The morphogenetic move-
ments of gastrulation carry the PGCs from the extreme periphery
into the hindgut. PGCs subsequently migrate through the hind-
gut epithelium, and once in the surrounding mesoderm, resolve
into two bilateral clusters that move toward each developing go-
nad. After arriving at the gonad, they differentiate according to
the male or female program, which is specified by the soma (re-
viewed in Kunwar et al., 2006). Mouse PGCs travel a surprisingly
similar route, though their origins differ (see Figure 1A). Anointed
from the pluripotent epiblast by a series of signals around embry-
onic day 7 (E7), murine PGCs traverse the epicenter of gastrula-
tion, the primitive steak, to the extraembryonic region (Anderson
et al., 2000). This peripheral positioning of PGCs is reminiscent of
fly pole cells. The exiled PGCs return to the embryo following
gastrulation and at the nascent endoderm become incorporated
into the hindgut (Molyneaux et al., 2001). Similar to Drosophila,Cell 132, 612–630, February 22, 2008 ª2008 Elsevier Inc. 613
mouse PGCs emerge from the gut, migrate into the dorsal
mesentery, and bifurcate as they approach the gonads, finally
arriving around day 11.5 of gestation. By contrast, zebrafish
PGCs travel a less linear route to the gonad (Figure 1D). They be-
gin not as a single cohort, but as four randomly oriented clusters
that converge on two regions of mesoderm during early gastru-
lation, then aggregate on either side of the first somites (Yoon
et al., 1997). Zebrafish PGC migration concludes similarly to fly
and mouse, with directed movements through mesoderm to
colonize the gonads (Raz, 2003).
Although the migration routes differ between these three phy-
logenetically distantmodel organisms, the interstitial migration of
PGCs in all cases proceeds in discrete steps and targets succes-
sive anatomical landmarks. Each step in PGCmigration involves
a specific kind ofmovement—from squeezing between epithelia,
to drifting through mesentery, to passive transit within the hind-
gut—and PGCs in various organisms progress through each mi-
gration step vacillating from polarized ameboid cells, to rounded
individual cells, to aggregated cells (Blaser et al., 2005; Godin614 Cell 132, 612–630, February 22, 2008 ª2008 Elsevier Inc.Figure 1. Migration of Germ Cells and
Blood Cells during Development
(A) Primordial germ cell (PGC) precursors in the
mouse epiblast move through the primitive streak,
become committed PGCs in the allantois (yellow
denotes extraembryonic tissues), then migrate
into the developing hindgut. PGCs then emerge
into the dorsal mesentery and colonize the go-
nadal ridges, which develop into the gonad.
(B) Mouse HSC progenitors and primitive blood
cells also migrate through the primitive streak to
the yolk sac; HSCs arise later in the placenta
and aorta-gonad-mesonephros region (AGM)
and then home through the embryonic and extra-
embryonic vessels to the fetal liver before coloniz-
ing the bone marrow.
(C) Relative positions of PGCs (blue) and HSCs
(red) in the mouse embryo at E10.5.
(D) Zebrafish PGCs are specified as four clusters
in the deep cell layer of the pregastrula. They mi-
grate into two regions of mesoderm before sepa-
rating into clusters flanking the somites, finally
moving into the gonads.
(E) Hematopoiesis in zebrafish begins later as
three transient populations: macrophages in the
cephalic mesoderm (which enter circulation via
the yolk sac), erythrocytes (which arise in the ven-
tral mesoderm), and erythromyeloid progenitors
(which arise in the posterior blood islands).
HSCs are specified in the AGM and migrate to
the thymus and the pronephros, which, like the
bone marrow in mammals, is the main site of adult
hematopoiesis.
(F) PGCs, HSCs, and blood progenitors in the ze-
brafish at 24–28 hours postfertilization.
et al., 1990; Molyneaux et al., 2001). Is
this morphological progression simply
a perfunctory response to the obstacle
course that lies between the birthplace
of PGCs and their arrival at the gonad,or does their meandering provide factors necessary for PGC de-
velopment and function? The answer still is not clear: mouse
PGCs progress through these morphological changes in vitro,
suggesting that at least some of their behavior is autonomous
(Godin et al., 1990), but heterochronic (interstage) transplants
in fish and flies suggest that the niche plays an instructive role
in their development (Blaser et al., 2005; Jaglarz and Howard,
1994). What is perhaps even more puzzling than the remarkable
length and complexity of the PGCpilgrimage to the gonad is their
disparate origin from the gonad. Would it not be more efficient to
generate the germ lineage where (and when) it is needed, rather
than conveying PGCs throughout the embryo and risking losing
them along the way? A surprising realization upon comparing
PGC development across different species is that the route
from PGC inception to arrival in the gonad seems to be perpetu-
ally changing; yet, perhaps such variation in the specific paths
of PGC migration belies a conserved requirement for migration
itself. Furthermore, when comparing PGC migration to that of
other developing stem cells, a remarkable theme emerges in
which a small number of founder cells expands while transiting
through successive anatomic sites. These observations suggest
that for many stem cells migration is more than just practical and
represents an essential aspect of their development and perhaps
even maintenance.
Blood
In contrast to the simple bipotentiality of PGCs, which generate
either oocytes or sperm, hematopoietic stem cells (HSCs) give
rise to many different types of mature blood cells through
a branching series of progenitors with increasingly restricted
potential (see Review by S.H. Orkin and L.I. Zon, page 631 of
this issue). Furthermore, unlike the leisurely germ cell whose ser-
vices will not be required until adulthood, HSCs must from the
start balance the immediate physiological demands of the grow-
ing embryo with the need to produce sufficient reserves for sus-
taining hematopoiesis throughout life. Moreover, whereas PGCs
navigate predominantly along interstitial routes, HSCs often
home to distant sites by making use of passive transport via
the circulating blood. Nonetheless, the development and move-
ment of blood and germ stem cells in the embryo share surpris-
ing similarities, beginning with their early specification, to their
sojourn to extraembryonic tissues in mammals, to their serial
stopovers in distinct embryonic sites. In addition, the cellular
phenotype of HSCs, like PGCs, is not static during development,
but changes to reflect different kinds of migration and different
hematopoietic requirements.
Although the earliest studies on blood development were car-
ried out in birds and amphibians, the mouse ultimately became
the main model organism in this field. Surprisingly, it remains un-
clear even today precisely when and where the very first HSCs
are established. Mouse hematopoiesis first becomes evident in
the yolk sac just after gastrulation at E7.5 as a band of special-
ized nucleated erythrocytes called blood islands (Figure 1B)
(Moore and Metcalf, 1970). Grafting studies into newborn recip-
ients detect the first HSCs at E9.0 in the yolk sac and para-aortic
splanchnopleurae, a mesoderm-derived tissue that becomes
the aorta-gonad-mesonephros (AGM) region around E10.5
(Yoder et al., 1997). However, earlier commitment to the HSC lin-
eage has been implied by genetic marking of the first Runx1+
cells in the yolk sac blood islands (Samokhvalov et al., 2007)
and by successful adult engraftment of E8.5 splanchnopleural
HSCs after a culture period (Medvinsky and Dzierzak, 1996).
In addition to the AGM and yolk sac, the placenta is the most
recently appreciated and prolific source of HSCs in the develop-
ing mouse embryo (Gekas et al., 2005; Ottersbach and Dzierzak,
2005). It is possible that developing hematopoietic precursors
emerging from the primitive streak remain in the allantois, which
fuses with the chorion and contributes to the umbilical cord and
placenta; alternatively, HSCs might arise de novo in the placenta
(Corbel et al., 2007). This second possibility has now been sup-
ported by a new study documenting the emergence of HSCs in
the placenta of embryos that lack blood circulation due to failure
to initiate a heartbeat (Rhodes et al., 2008).
At E11.5–12.5 of mouse development, a hematopoietic dias-
pora ensues, as HSCs abandon the yolk sac, AGM, and placenta
and home to the fetal liver (Johnson and Moore, 1975), which for
the next 5–6 days promotes both rapid HSC expansion and dif-
ferentiation to pools of various blood progenitors. Just 1–2 daysbefore birth, stem and progenitor cells begin to seed the bone
marrow (Christensen et al., 2004). Soon after their arrival at this
site of continued adult hematopoiesis, fetal mouse HSCs curb
their proliferative activities and enter a state of relative quies-
cence (Bowie et al., 2006). Yet, HSC migration is hardly finished.
Indeed,HSCmigration persists throughout adulthoodwith a con-
tinuous recirculation throughout the blood, tissues, and lym-
phatic system (Abkowitz et al., 2003; Massberg et al., 2007;
Wright et al., 2001).
The zebrafish has only recently become a standard model for
studying hematopoiesis and HSC development. Due in part to
differing requirements associated with external development,
the sites of early blood formation in zebrafish are quite distinct
from those in the mouse. Multipotent HSCs are preceded by
three separate populations of precursors with limited potential
and self-renewal capacity (Figure 1E): a population of primitive
macrophages arises from the cephalic mesoderm (Herbomel
et al., 1999), erythrocytes develop in migrating strips of ventral
mesoderm that converge into the cardinal vein (Al-Adhami and
Kunz, 1977), and progenitors with erythromyeloid potential orig-
inate in the posterior blood islands (PBI) (Bertrand et al., 2007). A
relevant evolutionary question is whether these evanescent
blood lineages existed prior to HSCs, or if their evolution fol-
lowed that of HSCs to satisfy increased metabolic or immune re-
quirements of the growing embryo. The first HSCs were recently
prospectively isolated from the zebrafish AGM equivalent. These
cells home through the vasculature to the thymus and via the
pronephric tubules to the head kidney, which is the site of adult
hematopoiesis equivalent to the bone marrow in mice (D. Traver,
personal communication). Thus, in spite of their evolutionary dis-
tance, the origination and migration of blood-forming stem cells
are remarkably similar between fish and mammals.
Considered in both rodent and teleost model systems, HSCs
migrate during development for comparatively less abstract rea-
sons than PGCs; practically speaking, blood cells are required
by the embryo before the formation of adult stem cell niches (lo-
cated predominantly in the bone marrow in mammals). As we
begin to attribute distinctive niche functions to particular HSC
stopovers throughout embryogenesis, such as rapid expansion
in the mammalian fetal liver and controlled quiescence in the
bonemarrow in mammals or head kidney in fish, the question re-
mains whether the earliest HSCs are specified more than once
and in several locations. Does this multicentered approach re-
flect phylogeny or a demand for production volume? Or, is there
an important functional heterogeneity between HSCs derived
from different sites of de novo hematopoiesis? Comparative
studies of blood development in multiple organisms will help to
answer this question, and such studies will certainly benefit
from recently acquired capabilities for prolonged live imaging
of zebrafish embryos, which marry lineage tracing and genetics
to directly monitor HSC origins and migration.
Skeletal Muscle
Skeletal muscle is a highly specialized tissue comprised of
nondividing multinucleated myofibers that contract in concert
to generate force (Figure 3). The ontogeny and migration of skel-
etal muscle precursors is highly conserved in vertebrates, and
our current understanding is a synthesis of studies in amphibian,
chick, mouse, and zebrafish. During development, cells thatCell 132, 612–630, February 22, 2008 ª2008 Elsevier Inc. 615
ultimately give rise to skeletal muscle originate from somites,
segmented parcels of paraxial mesoderm that flank the neural
tube (Buckingham et al., 2003). These precursors to adult skele-
tal muscle migrate great distances to multiple sites of embryonic
myogenesis, including the limb buds and brachial arches, where
differentiation ensues in late fetal stages. Myogenic differentia-
tion in these locations is accompanied by expression of themyo-
genic transcription factors Myf5 and MyoD and the fusion of cell
bodies (reviewed in Buckingham et al., 2003; Hawke and Garry,
2001). After this initial establishment of the muscle, the primary
myogenic requirement shifts from morphogenesis during devel-
opment, to growth and repair in postnatal life.
To meet the demands of postnatal life, fully developed muscle
retains a reservoir of cells committed to muscle regeneration.
First identifiedultrastructurally, these ‘‘satellitecells’’werenamed
for their peripheral location beneath the basal lamina of the myo-
fiber (Mauro, 1961). Satellite cells persist from late embryogene-
sis, to neonatal stages and through adulthood, although their
numbers decline after birth (Hawke andGarry, 2001). In the adult,
transplantation studies demonstrate both differentiation and
self-renewal capacities within the satellite cell pool, supporting
their designation as a tissue-specific stemcell population (Collins
et al., 2005; Montarras et al., 2005).
Recently, the developmental predecessors to muscle satellite
cells were identified in the late fetus based on their lack of differ-
entiation markers and continued expression of the paired box
transcription factors Pax3 and Pax7. Grafting experiments in
chick and genetic marking in mice suggest a common origin in
the dermomyotome for satellite cells and skeletal muscle (Gros
et al., 2005; Relaix et al., 2005). Satellite cell precursors, which
seed embryonic myogenesis and give rise to the postnatal satel-
lite cell pool, delaminate (split off) from the somites early in em-
bryogenesis, and migrate large distances to multiple sites of
myogenesis within the developing limbs and trunk (reviewed in
Buckingham et al., 2003). But precisely when is the fetal satellite
cell lineage established, and how is the specialized subset of this
pool set aside to give rise to adult self-renewing satellite cells?
Although the answers to these questions remain uncertain, it is
clear that targeted migration of both satellite cells and their pre-
cursors during development is critical for the morphogenesis
of muscle and that the mechanisms involved in this process
overlap in many ways with stem cell trafficking events in the
adult.Trafficking Mechanisms in Development
Cell-Cell Adhesion and Deadhesion
The regulation of adhesion between cells is critical for the transi-
tion of stem cells between different tissues during development.
In most cases, the breaking of existing junctions between cells,
or deadhesion, represents the earliest step in migration. For
muscle precursor cells in the somites, the onset of migration
requires dissociation of Pax3-expressing precursors from the
dorsal epithelial layer of the somite, or dermomyotome (Bucking-
ham et al., 2003). Pax3 transcriptionally regulates the tyrosine
kinase receptor c-Met (Epstein et al., 1996), which binds to
secreted hepatocyte growth factor. Regional concentrations of
hepatocyte growth factor in the developing limbs and brachial616 Cell 132, 612–630, February 22, 2008 ª2008 Elsevier Inc.arches engage c-Met and induce the dispersion of satellite cell
precursors along routes of myogenesis (Bladt et al., 1995).
Such epithelial-to-mesenchymal transitions (EMT) are a wide-
spread developmental strategy for generating new cell lineages;
the associated breakdown of apical junctions permits freemove-
ment of defecting cells relative to the uniform epithelial sheet
(reviewed in Shook and Keller, 2003). Zebrafish PGC migration
similarly begins with EMT, sparked by the expression of dead
end, a germline-specific RNA-binding protein. In dome stage
embryos, dead end downregulates the adhesion molecule
E-cadherin in the 4 PGC clusters in the deep epithelial layer
and enables their migration (Shimizu et al., 2005).
Migrating PGCs passing through the hindgut epithelium avoid
adhesive interactions similar to mesenchymal cells undergoing
EMT. PGCs in mice maintain low levels of E-cadherin compared
to the surrounding gut epithelial cells, which may enhance their
motility. Curiously, these cells upregulate E-cadherin upon egress
from the gut to the surrounding dorsal mesentery (see Figure 1C),
perhaps to facilitate adhesion to one another (Bendel-Stenzel
et al., 2000). The role for cadherins in transepithelial migration of
fly PGCs through the midgut is comparatively less clear, as it is
expressed but not absolutely required (Kunwar et al., 2003).
Mouse HSCs and their precursors in the yolk sac, AGM, and
placenta robustly express CD144, also known as vascular endo-
thelial (VE) cadherin, and CD144 levels fall as they transit to the
fetal liver (Fraser et al., 2002; Taoudi et al., 2005). Homotypic as-
sociation through VE-cadherins on endothelial cells is essential
for adherens junctions and regulates vascular permeability (Cor-
ada et al., 1999). The function of VE-cadherins in embryonic and
fetal HSCs is not clear, although cadherins may be biologically
important for both trafficking and niche interactions unique to
prenatal HSCs (Taoudi et al., 2005). These shared and unique
mechanisms of homotypic adhesion and deadhesion collectively
permit stem cells to migrate individually through sheets of cells.
Thus, a balance between engagement and aloofness from their
neighbors maintains stem cell dispersion, promotes movement,
and possibly helps to orient migrating stem cells in three-dimen-
sional space.
Movement
Integrin-mediated adhesion is important for the movement of
HSCs throughout mouse embryogenesis and in adulthood.
Distinct profiles of integrin heterodimer expression by HSCs in
different locations and at different developmental time points
suggests that integrins help to determine homing specificity. In
themouse, CD41/integrin a2b is strongly expressed by prospec-
tive HSCs in the para-aortic splanchnopleure, placenta, and yolk
sac from E8.5 onward. Expression gradually decreases during
maturation and becomes undetectable in fetal liver HSCs by
E11.5–12.5 (reviewed in Mikkola and Orkin, 2006). The function
of CD41 is not known, although its expression in the earliest
zebrafish HSCs suggests a conserved role in hematopoietic
commitment or retention in the early niche (D. Traver, personal
communication). Nonetheless, blood-island, embryonic, and
adult hematopoiesis appear normal in mouse embryos lacking
CD41, perhaps belying its functional redundancy in mammals
(Francis et al., 2002). PGCs in themouse express several integrin
subunits (a5, a6, b1, and b3), although only b1 appears to be es-
sential for migration. In mouse chimeras, b1-integrin-deficient
PGCs accumulate along their migration route, in the hindgut and
mesentery, and very few successfully populate the gonad (An-
derson et al., 1999). Taken together, these data indicate that
the combinatorial display of integrins on stem cell membranes
changes dynamically during development and has functional
consequences in the migration of multiple types of stem cells.
With the increasing feasibility of large-scale analyses, such as in-
travital and molecular imaging and transcriptional profiling on
small populations of cells, it will be possible to directly correlate
integrin expression on stem cells with their location and behav-
iors in various niches. Such approaches will define markers for
the isolation of stage-specific stem cells in development and
will clarify the functional role of particular integrin heterodimers
in migration.
Guidance Factors
Stem cells in the embryo rely on multiple navigation systems for
choreographing their discrete, successive movements. Genetic
screens in Drosophila suggest that phylogenetically ancient
guidance systems depend on lipids and factors requiring lipid
modification. Three independent mutants in the mevalonate
pathway disrupt PGC migration in fly embryos (Table 1) (re-
viewed in Kunwar et al., 2006). Mevalonate is involved in the syn-
thesis of cholesterol and isoprenoids, but the absence of genes
regulating cholesterol synthesis in Drosophila argues that the
protein prenylation pathway is required for PGC guidance.
Lipids may function more directly in fly PGC navigation by
activating the receptors Wunen1 and Wunen2, resulting in de-
flection of PGCs from midline tissues (Starz-Gaiano et al.,
2001; Zhang et al., 1997). Vertebrate Wunen homologs respond
to phospholipid substrates including sphingosine-1-phosphate
(S1P) and lysophosphatidic acid (LPA) (Renault et al., 2004 and
references therein). Both phospholipids and their receptors,
the S1P or Edg family, also regulate migration of mammalian
lymphocytes, endothelial cells, and cardiac progenitors (re-
viewed in Saba, 2004), although a role in vertebrate PGC guid-
ance has not been reported. These observations collectively
imply that lipid-mediated guidance has been reused by a variety
of migrating cell types in multiple organisms, although evolution
has not conserved these mechanisms in specific cell lineages.
Strategies for cellular repulsion and avoidance also appear to
have evolved multiple times and are invoked by many migrating
cells, including stem cells. For example, members of the ephrin
family of receptor tyrosine kinases and their membrane-bound
Eph ligands mediate axon guidance in the developing nervous
system, as well as neural crest, endothelial cell, and satellite
cell migration (reviewed in Davy and Soriano, 2005). In the chick
embryo, EphA4 enables satellite cell precursors delaminating
from the dermomyotome to avoid regions of EphA5 expression
in the limb mesoderm (Swartz et al., 2001). Ephrin signaling
between engaged ligand and receptor-bound cells produces
attractive as well as repulsive guidance cues, depending on
the family members (Davy and Soriano, 2005).
Similar attraction-repulsion responses arise from cellular
contact between early mouse PGCs; however, in this case the
molecular machinery involves a family of cell surface receptors
called IFITM/Mil/Fragilis. In the allantois of the mouse embryo,
PGC contenders may seal their commitment to the germline
via IFITM3 homotypic interactions (Saitou et al., 2002; Yoshimizuet al., 2001). Interestingly, IFITM1 in neighboring somatic cells
furnishes a repulsive signal that drives PGCs from the allantois
back into the embryo, whereas IFITM3 expressed by PGCs is
sufficient for their localization in the hindgut endoderm (Tanaka
et al., 2005). IFITMs are not exclusive to the germ lineage, as
other family members are found on lymphocytes (i.e. Leu-13)
and play a role in lymphocyte homing by modulating L-selectin
levels (Frey et al., 1997). Further studies may reveal common
signaling pathways downstream of various IFITM receptors in
PGCs and lymphocytes.
An important and pleiotropic guidance factor for several stem
cells in the embryo is Kit ligand (KitL). KitL and its receptor, c-kit,
were first studied 60 years ago in spontaneous mouse mutants
called Steel (Sl) andWhite spotting (W), which had nearly identi-
cal dominant coat-color phenotypes. Homozygous Sl and W
mouse embryos exhibit a profound PGC deficit, severe anemia,
and failure of neural crest-derived melanocyte migration
(Fleischman, 1993; Mintz and Russell, 1957). In PGCs, the c-kit
tyrosine kinase receptor promotes both survival and chemotaxis
in response to KitL, which is expressed by somatic cells along
the PGC migration route in the hindgut and dorsal mesentery
(Matsui et al., 1990; Runyan et al., 2006).
Embryonic and adult mouse HSCs also maintain high levels of
c-kit on their surface from E9.0 onward (Yoder et al., 1997). In the
fetal liver, KitL exerts chemoattractive effects on HSCs, suggest-
ing that it helps to retain them there during the last days of ges-
tation (Christensen et al., 2004). Given the distribution of KitL
expression during mid-development in relation to PGC and
embryonic HSC migration routes (Matsui et al., 1990), it is sur-
prising that the respective stem cells do not confuse one
another’s signals. How do PGCs moving through KitL+ territory
in the dorsal mesentery avoid the dorsal aorta endothelium,
which also expresses high levels of KitL? Conversely, do HSCs
lining the dorsal aorta escape along PGC conduits in the sur-
rounding mesentery?
Similar signal crossing also could confound the responses of
different stem cells to the growth factor chemokine stromal-de-
rived factor 1 (SDF-1a/CXCL12). SDF-1a induces chemotaxis of
mouse fetal liver HSCs in synergy with KitL (Christensen et al.,
2004); mouse embryos deficient in SDF-1a or its G protein-cou-
pled receptor CXCR4 (also known as fusin) develop severe
hematopoietic defects (Ma et al., 1998; Nagasawa et al., 1996;
Zou et al., 1998). SDF-1a , like KitL, also provides a survival as
well as a guidance signal to mouse PGCs in their final movement
toward the gonadal ridges (Ara et al., 2003; Molyneaux et al.,
2003). PGCs apparently co-opted chemokine signaling early in
vertebrate history and maintained it, as evidenced by its impor-
tance in mammals, fish, and birds. Zebrafish PGCs, unlike those
in chicks and mice, thoroughly depend upon SDF-1a/CXCR4-
mediated guidance throughout all steps of migration (Knaut
et al., 2003; Stebler et al., 2004).
Muscle satellite cells have also exploited CXCR4 and SDF-1a
for long-distance migration during development. Recent work in
the chick embryo demonstrated that SDF-1a in the limb mesen-
chyme and brachial arches suffices as a target for satellite cell
precursors following their delamination from the dermomyo-
tome. In satellite cells, CXCR4 interacts genetically with Gab1,
an adaptor molecule involved in signal transduction via c-MetCell 132, 612–630, February 22, 2008 ª2008 Elsevier Inc. 617
Table 1. Molecular Mechanisms Involved in Stem Cell Trafficking during Development
Mechanism PGCs HSCs Satellite cells
Involved in
homing
(blood to
tissue)?
Involved in
interstitial
navigation? References
Chemoattraction
c-Kit/KitL survival,
migration
(mouse, not
fish)
chemotaxis,
fetal liver
retention
(mouse not fish)
? maybe yes (Christensen et al., 2004;
Matsui et al., 1990; Mintz and
Russell, 1957; Parichy et al.,
1999; Runyan et al., 2006;
Yoder et al., 1997)
CXCR4/
SDF-1a
survival
(mouse),
migration
(mouse, fish)
homing to fetal
liver, BM
(mouse)
chemotaxis of
precursors to
limb, inhibits
differentiation
yes yes (Ara et al., 2003;
Christensen et al., 2004;
Knaut et al., 2003; Ma et al.,
1998; Molyneaux et al., 2003;
Nagasawa et al., 1996;
Vasyutina et al., 2005;
Zou et al., 1998)
Repulsion/Attraction
Ephrins ? ? EphA4-EphA5
mediate
avoidance
no yes (Swartz et al., 2001)
IFITM/Mil/
Fragilis
(Leu-13 in
lymphocytes)
IFITMs drive
PGCs into
endoderm;
PGC-PGC
interaction
(mouse)
? ? yes yes (Frey et al., 1997; Tanaka et al.,
2005; Yoshimizu et al., 2001)
Lipids Wunens:
guidance and
survival (fly);
mevalonate
pathway (fly)
S1P/Edg
receptors bind
SIP, LPA to
regulate
lymphocyte
migration
? maybe yes (Kunwar et al., 2006;
Saba, 2004)
Adhesion/Movement
Cadherins E-cadherin
downregulation
with onset of
migration
through
epithelia (fish,
mouse)
VE-cadherin
expressed by
committing
HSCs (mouse)
N-cadherin
retains satellite
progenitor
daughters in
dermomyotome
no yes (Bendel-Stenzel et al., 2000;
Fraser et al., 2002; Shimizu et al.,
2005; Taoudi et al., 2005;
Weidinger et al., 1999)
c-Met/HGF ? ? delamination
from
dermomyotome
no yes (Dietrich et al., 1999;
Epstein et al., 1996)
Integrins b1-integrin,
PGC homing
(mice)
CD41 expressed
on early HSCs
(mouse, fish);
b1-integrin essential
for fetal liver
and BM colonization
a6b1-integrin
involved in
migration to the
myotome
yes yes (Anderson et al., 1999; Bajanca
et al., 2006; Bertrand et al., 2005;
Potocnik et al., 2000)
Abbreviations: BM, bone marrow; HGF, hepatocyte growth factor; HSC, hematopoietic stem cell; IFITM, Interferon-inducible transmembrane recep-
tor, PGC, primordial germ cell; S1P, sphingosine-1-phosphate; SDF-1a, stromal derived factor-1a; question mark indicates lack of evidence of
involvement.618 Cell 132, 612–630, February 22, 2008 ª2008 Elsevier Inc.
(Vasyutina et al., 2005), which regulates the survival and dis-
persal of satellite cell precursors (Sachs et al., 2000). Down-
stream integration of CXCR4 and c-Met signaling pathways con-
trols both migration and survival of satellite cell precursors. In
light of these data, it will be interesting to dissect the molecular
crosstalk between GPCR and receptor tyrosine kinase signal
transduction in adult satellite cells and to ask whether these
pathways also converge in embryonic PGCs or HSCs. Curiously,
SDF-1a appears to be a relatively common stem cell guidance
cue and is used among multiple vertebrate classes and by all
three stem cells considered here. As we continue to compare
the development and migration of stem cells in additional organ-
isms, it may become clearer whether SDF-1a/CXCR4 represents
a primordial navigation system of vertebrates, upon which addi-
tional migratory pathways are layered, or whether among many
early migration mechanisms, SDF-1a/CXCR4 became a refined
evolutionary survivor.Stem Cell Trafficking in Adult Tissues
As in development, stem cell homing and migration are critical
for the ongoing replacement of mature cells and regeneration
of damaged cells in many adult tissues. Stem cell function in
adult tissue repair and replacement often recapitulates the pro-
cesses that gave rise to these cells and enabled their dissemina-
tion during development. Thus, comparative analysis of devel-
opmental and regenerative stem cell function can help to
inform studies of the crucial signaling pathways that mediate
stem cell movement in the body.
Blood
In the adult hematopoietic system, multipotent clonogenic HSCs
give rise to billions of new mature blood cells each day (see Re-
view by S.H. Orkin and L.I. Zon). These cells replenish circulating
pools of red and white blood cells whose effector functions limit
their lifespan and necessitate their replacement from self-renew-
ing precursors. Migration and homing are thus key components
of normal adult hematopoiesis and are required for the dissem-
ination and function of mature blood cells throughout the body.
As discussed below, controlled migration appears to be a key
feature of normal HSC activity as well (Figure 2).
In adult mice and humans, the majority of HSCs are found in
the bone marrow, but HSCs are also constitutively present at
low levels in the circulation. Circulating HSCs have been
detected in the blood phenotypically and functionally, both by
direct transplantation of peripheral blood cells and by analysis
of parabiotic mice—animals surgically joined so that they share
a common blood circulation (Abkowitz et al., 2003; Massberg
et al., 2007; Wright et al., 2001). Significantly, parabiosis ex-
periments directly demonstrate that circulating HSCs rapidly
HSCs exit the blood in various peripheral organs where they spend36 hr be-
fore entering the draining lymphatics in a manner that depends on sphingo-
sine-1-phosphate (S1P) and the S1P receptor. S1P level are high in the lymph
but very low in tissues due to degradation by S1P lyase. While in peripheral tis-
sues, HSCs can divide and differentiate, presumably to replenish tissue-resi-
dent myeloid cells. Exposure of tissue-resident HSCs to agonists for Toll-like
receptor (TLR) 2 or TLR4 markedly amplifies HSC differentiation along the my-
eloid lineage. Through this mechanism, migratory HSCs contribute to immune
surveillance by the innate immune system.Figure 2. Migratory Routes of Adult HSCs
The majority of HSCs reside in the bone marrow where they undergo self-
renewal and give rise to differentiated hematopoietic cells; however, some
HSCs continuously leave the marrow and enter the blood. At the top, circulat-
ing HSCs can re-enter the marrow through sinusoids, which constitutively ex-
press trafficking molecules that support a unique multistep adhesion cascade
for HSC homing. Initially, free-flowing HSCs are tethered to the vessel by the
vascular selectins, E- and P-selectin, which bind to sialyl-Lewisx-like carboy-
drate ligands that are associated with PSGL-1 and CD44 on HSCs. Selectin
binding, together with engagement of endothelial VCAM-1 with the integrin
VLA-4 (a4ß1), mediates HSC rolling in marrow sinusoids. The rolling HSCs
are then activated by the chemokine CXCL12, which binds to the G protein-
coupled receptor, CXCR4. The chemokine signal is thought to induce a rapid
conformational change in the VLA-4 heterodimer (VLA-4*) that results in in-
creased affinity for VCAM-1 and permits the rolling cells to arrest. Adherent
HSCs then emigrate into the extravascular bone marrow compartment, pre-
sumably following extracellular chemoattractant signals transduced via G pro-
tein-coupled receptors expressed by HSCs. At the bottom, some blood-borneCell 132, 612–630, February 22, 2008 ª2008 Elsevier Inc. 619
re-engraft the bone marrow at distinct locations and functionally
contribute to ongoing hematopoiesis (Abkowitz et al., 2003;
Wright et al., 2001). Moreover, HSC crossengraftment in parabi-
otic mice occurs in the absence of hematopoietic ablation and
does not involve surgery-induced inflammation (Wright et al.,
2001). These data suggest that blood circulation is a normal
physiological activity of HSCs.
Recently, the in vivo circuit of HSC recirculation has been fur-
ther explored in mice, revealing the remarkable journey of these
cells from the marrow into the blood, from the blood into multiple
tissues (including liver, kidneys, and lung), from the tissues into
the lymph, and from the lymph back into the blood, where they
may return to the marrow or enter another cycle of transit (Fig-
ure 2) (Massberg et al., 2007). Although the biological rationale
for this nomadic behavior is not entirely clear, one strong possi-
bility is that the constitutive circulation of HSCs through periph-
eral tissues provides a rapidly recruitable source for local pro-
duction of immune and inflammatory effector cells (Massberg
et al., 2007). Such effectors generated ‘‘on the spot’’ enable
fast and effective eradication of subthreshold infections, clean
up circumscribed regions of cell death, and replenish rare tis-
sue-resident leukocytes such as dendritic cells that are lost in
the course of infection. In addition, analysis of mutant mice lack-
ing the transcription factor early growth response 1 (Egr1) show
enhanced HSC proliferation in the bone marrow, coupled with
normal numbers of marrow HSCs and a constitutive increase
in peripheral blood HSCs (I.M. Min and A.J.W., unpublished
data). These findings suggest that regulated release of HSCs
into the circulation also may help to limit overaccumulation of
these cells in the marrow environment.
The efficiency with which HSCs re-engraft the marrow in un-
manipulated animals appears to depend directly on the availabil-
ity of open niches, which constantly turn over at a low rate (Bhat-
tacharya et al., 2006). In parabiotic mice, HSC chimerism can be
enhanced by hematoablative drugs and cytokines that induce
the movement of endogenous cells out of the marrow niche (Ab-
kowitz et al., 2003). Likewise, hematopoietic engraftment follow-
ing transplantation in unirradiated animals can be significantly
enhanced by antibody-mediated depletion of the recipient’s
endogenous pool of HSCs (Czechowicz et al., 2007). Ultimately,
understanding how constitutive recirculation affects HSC func-
tion must await strategies that specifically block this migration.
Nonetheless, the importance of HSC homing pathways is
made clear by the reliance of clinical bone-marrow transplanta-
tion on the innate ability of transplanted HSCs to traffic efficiently
to the bone-marrow niche.
Transplantation of human bone-marrow cells or peripheral
blood progenitor cells (PBPCs) is a common treatment option
for patients with hematopoietic and nonhematopoietic cancers,
bone-marrow failure, or certain metabolic disorders. During he-
matopoietic cell transplant, donor HSCs contained within mar-
row or peripheral blood grafts are introduced intravenously into
recipients whose own blood-forming capacity has been partially
or completely abrogated by irradiation or chemotherapy. To suc-
ceed in regenerating the recipient’s blood system, these HSCs
must accurately and efficiently home to appropriate marrow
locations and engraft within available niches that support HSC
survival, expansion, and differentiation to regenerate mature620 Cell 132, 612–630, February 22, 2008 ª2008 Elsevier Inc.blood cells. This clinically important process of transplantation
is likely to use pre-existing pathways that normally support the
physiological recirculation of HSCs during steady-state hemato-
poiesis. Intravital microscopy studies in mouse bone marrow
have enabled the dissection of the multistep adhesion cascade
regulating hematopoietic stem and progenitor cell homing to
normal and irradiated bone marrow (Mazo et al., 1998, 2002)
and have implicated particular adhesion and chemotactic recep-
tors in this process (Table 2 and Figure 2).
In addition to blood-to-marrow homing, common clinical prac-
tice also exploits the reverse process of marrow-to-blood migra-
tion, a phenomenon known as ‘‘mobilization.’’ In fact, because
mobilization of HSCs into the circulation greatly facilitates their
collection for transplantation and appears to shorten the time re-
quired for recovery of normal levels of circulating blood cells in
some transplant recipients (Jansenet al., 2005),mobilizedperiph-
eral bloodcellsare increasinglypreferredwhencompared toother
stemcell sources for adult transplantation (http://www.imbtr.org).
Like transplantation, HSC mobilization may use pre-existing
physiological migratory pathways. Mobilization can be induced
by a wide variety of ‘‘mobilizing’’ agents, including antagonists
of adhesion and chemotaxis, cytotoxic drugs, and certain
cytokines. Interestingly, these agents often drive both HSC pro-
liferation and movement from the marrow to the bloodstream
(Morrison et al., 1997; Papayannopoulou, 1999), suggesting
a mechanistic link between HSC cell-cycle progression and mi-
gration. In this regard, it is interesting to note that the homing ef-
ficiency of transplanted HSCs (from blood to marrow) is directly
impacted by the position of HSCs in the cell cycle. In several
studies, the ability of HSCs to functionally engraft irradiated re-
cipients dramatically decreases as soon as they exit quiescence
(Bowie et al., 2006; Passegue et al., 2005), although the explana-
tion for this reduced engraftment potential remains unclear.
Skeletal Muscle
Adult skeletal muscle possesses remarkable regenerative ca-
pacity, with large numbers of new muscle fibers forming only
a few days after acute muscle damage (Hawke and Garry,
2001). This rapid repair is believed to occur through the action
of myogenically specified precursor cells contained within the
population of satellite cells located immediately adjacent to
and beneath the basal lamina of muscle fibers (Mauro, 1961;
Figure 3). In response to muscle growth and regenerative cues,
normally quiescent satellite cells become activated and divide,
migrate, and differentiate to form myoblasts that fuse with
each other and with existing muscle fibers to regenerate the
muscle (reviewed in Hawke and Garry, 2001).
Satellite cell activation, migration, and fusion all contribute to
the maintenance and regeneration of muscle mass in normal
and pathological conditions. Themigratory capacity of myogenic
satellite cells appears tobemodulatedby the integrity of thebasal
lamina. After rupture of the basal lamina due to injury or disease,
satellite cells migrate to adjacent myofibers via tissue bridges
(Watt et al., 1987). With more limited muscle injury where no rup-
tureof thebasal laminaoccurs, satellitecellsmay traverse themy-
ofiber underneath the basal lamina to the injury site. The signals
that initiate satellite cell movement along and between damaged
myofibers, as well as the molecular mediators of their migration,
are not well understood. However, some myofiber-associated
muscle stem cells contained within the satellite cell population
may possess unique migratory properties that allow their re-
engraftment into the satellite cell niche upon intramuscular trans-
plant (Collins et al., 2005;Montarras et al., 2005; Sherwood et al.,
2004). Re-entry into this niche after muscle damage allows
myogenic stem cells to repopulate and renew the stem cell com-
partment in the muscle, such that muscle regenerative activity is
maintained for subsequent rounds of injury repair.
Unlike HSCs, highly myogenic muscle satellite cells do not
appear to traffic naturally in the circulation, as no chimerism de-velops in this population in parabiotic mice, even after many
months of shared circulation (Sherwood et al., 2004). Recruit-
ment of myogenic satellite cells from the circulation is also not in-
duced following muscle injury (Sherwood et al., 2004), suggest-
ing that these cells do not possess appropriate adhesion and
signaling receptors to support their movement into or out of
the bloodstream. Even within the muscle, myogenic precursors
exhibit relatively limited mobility, although they do appear capa-
ble of contributing tomyofibers at some distance from their initial
site of activation within the muscle bed (Hughes and Blau, 1990).Table 2. Molecular Mechanisms Involved in the Trafficking of Stem Cells in the Adult
Mechanism HSCs Satellite cells
Involved
in homing
(blood
to tissue)?
Involved in
interstitial
navigation?
Pathway also
utilized during
development? References
Deadhesion
MMPs cleaves KitL
to generate soluble
KitL; important
for mobilization and
hematopoietic recovery
involved in
myoblast
migration
indirectly yes yes (in flies) (Carmeli et al., 2004;
Heissig et al., 2002;
Kollet et al., 2006)
Cathepsin K Produced by osteoclasts;
cleaves KitL and SDF-1a
? yes yes ? (Kollet et al., 2006)
CD26 Cleaves SDF-1a;
involved in mobilization and
homing to BM
? yes no no (Christopherson et al., 2003)
Chemoattraction
c-Kit/KitL BM homing
and retention
? yes yes yes (Bernstein et al., 1991;
Fleming et al., 1993)
CXCR4/
SDF-1a
BM homing
and retention
myoblast
chemotaxis
yes yes yes (De Paepe et al., 2004;
Ma et al., 1998;
Nagasawa et al., 1996;
Petit et al., 2002;
Ratajczak et al., 2003;
Zou et al., 1998)
Rho GTPases Rac1, Rac2,
cdc42: HSC
retention in BM;
homing to BM
regulates
M-cadherin
expression
yes yes yes (Cancelas et al., 2005;
Charrasse et al., 2006;
Gu et al., 2003)
Lipids (S1P) HSC recirculation
from tissues into
lymph
S1P signaling
induces proliferation
and cell contraction
no yes yes (Formigli et al., 2004;
Massberg et al., 2007;
Nagata et al., 2006)
Adhesion/Movement
Cadherins N-cadherin adhesion
implicated in some
but not all studies
M-cadherin binds
satellite cells
to the myofiber
no yes yes (Irintchev et al., 1994;
Kiel et al., 2007;
Zhang et al., 2003)
c-Met/HGF activation of
satellite cells
no yes yes (Tatsumi et al., 1998)
Integrins b1-integrin
essential for BM
homing; BM retention
involved in myoblast
migration, adhesion
and fusion
yes yes yes (Papayannopoulou, 2000;
Potocnik et al., 2000;
Schwander et al., 2003;
Taverna et al., 1998)
Abbreviations: BM, bone marrow; HGF, hepatocyte growth factor; HSC, hematopoietic stem cell; MMP, matrix metalloproteinase; S1P, sphingosine-
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Interestingly, other populations of cells that reportedly exhibit
myogenic activity in vivo—including blood vessel-associated
pericytes, mesangioblasts, and muscle side-population (SP)
cells—are able to engraft the muscle from the bloodstream
and to contribute to donor-engrafted muscle fibers following in-
tra-arterial (but not intravenous) delivery (reviewed in Peault
et al., 2007). The homing capacity of these alternative muscle re-
generative cells may in some instances be induced or enhanced
by cell culture (Galvez et al., 2006; Sampaolesi et al., 2003). Such
induced homing capacity may be an advantage for systemic
dissemination, but given the relatively poor myogenic activity
of these cells in comparison to canonical muscle satellite cells
(Collins et al., 2005; Montarras et al., 2005), and the potential
dangers (such as thrombosis) associated with intravascular cell
delivery, it is still unclear what constitutes the ‘‘best’’ population
for muscle cell therapy.
Trafficking Mechanisms of Adult Stem Cells
Taking blood and skeletal muscle as prototypical examples of
homeostatic (blood) and facultative (skeletal muscle) stem cell
populations, one can divide the events of physiological adult
stem cell movement into two distinct multistep processes. First,
because long-term maintenance of tissue-specific adult stem
cells typically requires association with a supportive stem cell
niche (see Review by S.J. Morrison and A.C. Spradling, page
598 of this issue), movement of these cells during the course
of steady-state or injury-induced replacement of mature daugh-
ter cells first requires stem cell mobilization from the niche. Yet,
to enable long-term stem cell maintenance, thesemobilized cells
also must eventually return to the niche, in a process comple-622 Cell 132, 612–630, February 22, 2008 ª2008 Elsevier Inc.mentary to stem cell homing. Mobilization and return of stem
cells to the niche invoke similar, although not identical, molecular
processes involving adhesion/deadhesion, chemoattraction/
chemoretention, and ultimately stem cell movement. In addition,
they often use the same molecular mediators, illustrating the
functional complementarity of these processes. Interestingly,
while stem cell mobilization often evokes stem cell proliferation,
return to the niche is typically accompanied by a return to mitotic
quiescence (Hawke and Garry, 2001; Morrison et al., 1997;
Passegue et al., 2005; Zammit et al., 2004).
Adhesion and Deadhesion
In both blood and skeletal muscle, the molecular mechanisms
underlying stem cell movement have been most studied in set-
tings of induced responses to tissue injury (that is, chemotoxic
drug treatments, irradiation, and transplantation). However, it is
likely that factors involved in injury-induced stem cell mobiliza-
tion and homing likewise mediate steady-state physiological
movements, suggesting that these same pathways will almost
certainly have relevance for homeostatic stem cell functions as
well. In any event, stem cell movement in vivo begins with release
of the stem cell from its protective environment, or niche. In the
hematopoietic system, this appears to occur constitutively
(Massberg et al., 2007; Wright et al., 2001), whereas in skeletal
muscle, the liberation of myogenic satellite cells seems to occur
almost exclusively in response to muscle damage (Hawke and
Garry, 2001).
For HSCs, deadhesion from the niche involves the elaboration
of proteolytic enzymes by both bone marrow hematopoietic and
stromal elements; such enzymes include matrix metalloprotei-
nase MMP-9 and the cysteine protease cathepsin K (HeissigFigure 3. Adhesion and Migration in Adult Skeletal Muscle
(A–D) Skeletal muscle is composed of bundles of multinucleatedmyofibers (A). Each fiber carries a rare population of primitive muscle satellite cells. Satellite cells
reside between the myofiber plasma membrane and the surrounding basal lamina, composed of collagen, laminin and other extracellular matrix-associated pro-
teins (B). When the muscle is injured, damaged muscle fibers and infiltrating blood cells (not shown) elaborate soluble mediators, such as SDF-1a, and satellite
cells become activated (C). Activated satellite cells proliferate and migrate along the myofiber (C) and through the muscle intersitium to adjacent myofibers (D) to
repair damage by fusion with survivingmyofibers and by de novomyogenesis. Shown in (B)’s inset is themuscle satellite cell niche. Satellite cells adhere tightly to
myofibers, and M-cadherin concentrates in the region of cell-cell contact. Satellite cells also adhere to the laminin-containing extracellular matrix (black line) via
b1-integrin heterodimers, and express the chemokine receptor CXCR4 and Syndecan coreceptors. These traffickingmolecules regulate satellite cell proliferation
and migration during muscle regeneration.
et al., 2002; Kollet et al., 2006). These enzymes act on extracel-
lular matrix proteins and secreted cytokines, including SDF-1a
and KitL (Kollet et al., 2006), both of which can modulate the
in vivo localization of HSCs and hematopoietic progenitors
(Fleming et al., 1993; Levesque et al., 2003). Recent data impli-
cate blood-lineage osteoclasts, bone-remodeling cells found of-
ten in the endosteal region of the marrow, in the release of HSCs
from their niche; direct cytokine stimulation of osteoclasts spe-
cifically increases circulating levels of hematopoietic precursors,
whereas in vivo inhibition of osteoclast activity reduces both the
physiological release and induced mobilization of hematopoietic
precursor cells (Kollet et al., 2006). The activity of proteases pro-
duced by HSCs themselves, such as the cell surface-expressed
dipeptidase CD26, also contributes to the silencing of HSC re-
tention signals in the marrow in part by cleavage-mediated inac-
tivation of SDF-1a (Christopherson et al., 2003). Activation of
protease activity likewise appears to regulate muscle satellite
cell function, and in vivo studies argue that MMP activity (likely
MMP-2, MT-MMP1, or MMP-9) is essential for the migration of
myogenic precursors during muscle regeneration (Carmeli
et al., 2004).
Based on expression studies, cadherin-mediated cell adhe-
sion has been suggested to facilitate HSC retention in the niche
(via N-cadherin) (Zhang et al., 2003) and to correctly position
muscle satellite cells along the muscle fiber (via M-cadherin)
(Irintchev et al., 1994). However, mice lacking M-cadherin
show no defects in skeletal muscle development or regeneration
(Hollnagel et al., 2002), and recent studies argue against the in-
volvement of N-cadherin in regulating HSCs (Kiel et al., 2007).
Thus, the precise role of cadherin-mediated binding in adhe-
sion/deadhesion of adult stem cells remains opaque, and it is
possible that other adhesion molecules, such as integrins,
support cadherin-like functions in adult tissues.
Satellite cells also express a number of other cell surface re-
ceptors implicated in cell-cell and cell-ECM adhesion, including
CD34, VCAM-1, NCAM, c-Met, syndecan-3, and syndecan-4
(reviewed in Peault et al., 2007 and Hawke and Garry, 2001). Al-
though in many cases the functional importance of these adhe-
sion receptors for satellite cell activation and myogenic function
remains obscure, analysis of relevant knockout mice suggests
that syndecans-3 and -4 are important for satellite cell-mediated
muscle regeneration. Syndecans are a family of cell surface-ex-
pressed heparin sulfate proteoglycans that act as coreceptors
for tyrosine kinases and play a role in cell adhesion. Mice lacking
syndecan-3 exhibit a progressive muscular dystrophy and aber-
rant in vitro differentiation of muscle satellite cells, whereas mice
lacking syndecan-4 show defects in muscle regeneration in vivo
and syndecan-4 null myocytes fail to proliferate properly when
cultured ex vivo (Cornelison et al., 2004). Nonetheless, normal
muscle morphogenesis in syndecan-knockout mice suggests
that thesemolecules are not critical for specification or migration
of myogenic precursors during development.
Chemoattraction/Chemoretention
Receipt of appropriate stem cell retention signals appears to be
essential for maintaining HSCs within the bone-marrow niche.
Like their fetal counterparts, adult HSCs express the chemokine
receptor CXCR4 and selectively respond to SDF-1a in chemo-
taxis assays in vitro (Wright et al., 2002). Administration of theCXCR4 antagonist AMD3100 effectively mobilizes HSCs in
both mice and humans (Broxmeyer et al., 2005), and proteolytic
degradation of SDF-1a in the bone marrow has been associated
with inducedmobilization of hematopoietic progenitor cells (Lev-
esque et al., 2003; Petit et al., 2002), although the necessity of
this degradation for mobilization has been questioned (Levesque
et al., 2004). Likewise, conditional ablation of CXCR4 in hemato-
poietic lineage cells results in loss of HSCs from the marrow
environment and reduced resistance to hematopoietic injury
(Sugiyama et al., 2006). Signaling downstream of CXCR4, via
the Rho family GTPases Rac1 and Rac2, also appears to be es-
sential for retention of HSCs in the marrow, as ubiquitous dele-
tion of both Rac1 and Rac2 or administration of small molecule
inhibitors of Rac proteins induces spontaneous mobilization of
HSCs and progenitors into the blood (Cancelas et al., 2005; Gu
et al., 2003). Interestingly, different chemotactic signals appear
to regulate the movement of HSCs out of tissues other than
the bone marrow. HSCs arrive in these peripheral organs via
the blood, but exit via the draining lymphatics in a manner that
depends on sphingosine-1-phosphate (S1P) and the S1P recep-
tor (Massberg et al., 2007). S1P levels are high in the lymph but
very low in tissues due to degradation by a S1P lyase (Figure 2C).
Thus, HSCs appear to respond to a gradient of S1P to exit pe-
ripheral tissues and enter the lymph, which enables their passive
transport and return to the blood via the thoracic duct.
Many of the same molecules that play a critical role in HSC
mobilization from the bone marrow have also been implicated
in the reverse process of HSC homing to the marrow from the
peripheral blood. For example, hematopoietic engraftment of
human HSCs in immunodeficient mice is blocked by inhibitory
antibodies to CXCR4 (Peled et al., 1999). Likewise, Rac1-defi-
cient mouse HSCs exhibit an impaired ability to migrate to the
marrow after transplant and, thus, are unable to effectively repo-
pulate recipient hematopoietic systems (Cancelas et al., 2005;
Gu et al., 2003). After arriving in the marrow, HSC engraftment
in the appropriate marrow location appears to depend addition-
ally on retention signals provided by divalent cations in the mi-
croenvironment. In particular, the Ca2+ sensing receptor is highly
expressed byHSCs, and transplanted HSCs that lack this recep-
tor home to marrow but show impaired lodgement in endosteal
niches (adjacent to the bone) (Adams et al., 2006). As a result
of their defective in vivo localization, HSCs lacking the Ca2+
sensing receptor ultimately fail to effectively engraft irradiated
recipients in competitive transplant assays (Adams et al., 2006).
Signaling via the CXCR4/SDF-1a axis also appears to be
involved in the action ofmyogenic precursor cells of adult skeletal
muscle. First, analysis of cell surface marker expression by skel-
etal muscle satellite cells (Sherwood et al., 2004) indicates that
a highly myogenic subset of these, which exhibit muscle stem
cell properties (M. Cerletti and A.J.W., unpublished data), can
be specifically enriched by expression of CXCR4. Therefore,
these cells likely respond directly to SDF-1a, consistent with re-
ports of SDF-1a upregulation in injured and regenerating skeletal
muscle (DePaepe et al., 2004) and chemotaxis ofmuscle satellite
cell lines in response toSDF-1a (Ratajczak et al., 2003). SDF-1a is
also involved in themigrationof rat neural precursor cells andmay
be important for attracting these cells to proliferate in the external
granule cell layer of the cerebellum in the brain (Reiss et al., 2002).Cell 132, 612–630, February 22, 2008 ª2008 Elsevier Inc. 623
Movement
As for HSC chemotaxis, HSC mobilization from the marrow and
homing to the marrow also appear to invoke an overlapping set
of cell surface-expressed adhesion receptors (Figure 2C). For
example, antibody-based inhibition of the integrin VLA-4 (a4b1)
or proteolytic degradation of its ligand VCAM-1 induces mobili-
zation of stem and progenitor cells in both mice and primates
(Levesque et al., 2001; Papayannopoulou, 2000). Conversely,
functional inhibition of VLA-4 during HSC transplant prevents
efficient hematopoietic reconstitution by blocking HSC homing
to the bone marrow and engraftment within the marrow niche
(Wagers et al., 2002). HSC homing from blood to marrow addi-
tionally invokes the activity of the endothelial adhesion mole-
cules, E- and/or P-selectin (Frenette et al., 1998; Mazo et al.,
1998).
As in the movement of HSCs, integrin-mediated cell adhesion
and migration is also essential for proper muscle repair by myo-
genic satellite cells. During the later stages of muscle regenera-
tion, interaction between the remodeled extracellular matrix and
integrins expressed by satellite cells facilitates the adhesion and
spreading of muscle precursors and thus establishes the organi-
zation of the regenerated muscle fibers (Disatnik and Rando,
1999; Zaidel-Bar et al., 2004). In addition, conditional inactivation
of the b1-integrin chain, a marker of highly myogenic stem cells
within the satellite cell population (Kuang et al., 2007; Sherwood
et al., 2004), in developing skeletal muscle leads to an accumu-
lation of unfused cells and a decrease in muscle fibers in mutant
muscles (Schwander et al., 2003).
In summary, drawing from examples in both the blood and
skeletal muscle, it is clear that a complex cascade of adhesive,
chemotactic, and signaling pathways acts cooperatively and in
concert to bring about the relocation of stem cells in the adult
organism. Moreover, many of the molecules and mediators sup-
porting stem cell migration and homing in adult tissues are
shared with migration systems utilized during embryogenesis,
suggesting a close conservation of the regenerative responses
of adult tissue stem cells and the organogenic activities of em-
bryonic and fetal precursors (Tables 1 and 2). Thus, the regulated
mobilization and homing of tissue-specific stem cells is crucial
for proper function of these cells in tissue homeostasis and
repair.
Stem Cell Trafficking and Disease
As a final parallel, we consider the role of stem cell homing in the
pathological activities of tumor-propagating cancer stem cells,
which like their normal counterparts, may rely on regulated adhe-
sion and migration to disseminate malignant clones exhibiting
a hierarchy of (dysregulated) cell differentiation. We also discuss
potential new strategies to exploit stem cell homing as a vehicle
for drug or gene delivery.
Cancer, Cancer Stem Cells, and Metastasis
An abnormal increase in progenitor cell frequency in the blood-
stream often correlates with neoplastic transformation. Like
normal hematopoietic cell migration, the trafficking of cancer
cells into and through the bloodstream relies on the expression
of specific cell adhesion and chemotactic factors. Migration
through the bloodstream allows dissemination of metastatic
cells in both hematopoietic and solid tumors, and in both cases,624 Cell 132, 612–630, February 22, 2008 ª2008 Elsevier Inc.specific adhesion/deadhesion pathways appear to determine
the efficiency of egress from the primary tumor site and the tro-
pism of the metastatic cells. For example, in a mouse model of
melanoma, ectopic expression of integrin a4b1 is sufficient to re-
tain tumors in situ (Qian et al., 1994), whereas in a distinct mouse
insulinomamodel, transgenic expression of the homing receptor
L-selectin (CD62L) is sufficient to direct metastasis to peripheral
lymph nodes (Qian et al., 2001). Finally, expression of chemokine
receptors, particularly CXCR4, has been associated with traf-
ficking and enhanced metastasis in several blood and solid
tumors including leukemia, lymphoma, multiple myeloma, breast
cancer, ovarian cancer, prostate cancer, renal cell carcinoma,
melanoma, and non-small-cell lung cancer (reviewed in Balkwill,
2004 and Burger and Kipps, 2006).
These data support the notion that neoplastic progenitor cells
take advantage of the same or similar mechanisms of migration
as those normally used by their nonmalignant counterparts and
by differentiated leukocytes. But do these mechanisms truly
reflect the in vivo movement of tumor propagating cancer stem
cells, and can they be targeted effectively to delay or impair
reseeding of malignancy at distant sites? In fact, current data
from a number of model systems lend increasing support to
the notion that many, although perhaps not all, malignancies
have at their root a rare population of cancer stem cells, which
maintains production of more differentiated malignant blasts
and is capable of transferring disease to otherwise normal sec-
ondary recipients (reviewed in Dalerba et al., 2007). Recent
work further suggests that marrow-derived non-neoplastic cells
may be necessary to form a ‘‘premetastatic niche’’ that directs
the organ-specific homing patterns of malignant carcinoma cells
(Kaplan et al., 2005). This premetastatic niche possesses unique
extracellular matrix properties and secretes chemoattractants,
such as SDF-1a, to recruit metastatic cancer stem cells to estab-
lish secondary tumors at distal sites (Kaplan et al., 2005). Impor-
tantly, interventions that prevent the establishment of this niche
appear also to block in vivometastasis, suggesting that targeting
the homing mechanisms of malignant cells may be an effective
strategy for limiting cancer spread.
Consistent with this notion that mobilization of malignant can-
cer stem cells is important in the establishment of metastatic tu-
mors, studies in a xenograft model of acute myelogenous leuke-
mia (AML) indicate that inhibition of leukemia stem cell (LSC)
migration to a putative leukemic niche by blockade of CD44-
dependent adhesion prevents leukemic engraftment (Jin et al.,
2006). Thus, interference with tumor cell migration could be
used to prevent or delay leukemic progression and cancer
spread. Conversely, because acquisition by cancer stem cells
of new adhesion receptor expression or function may confer
metastatic potential upon some tumors (Balkwill, 2004; Qian
et al., 1994, 2001), migration receptor expression profiling could
prove useful as a diagnostic and prognostic tool. These data
argue in favor of conserved mechanisms of cell deadhesion,
chemotaxis, migration, and homing in the dissemination of nor-
mal stem cells and of their malignant counterparts.
Stem Cells as Delivery Vehicles
The innate homing capacity of HSCs has been exploited clini-
cally in the repopulation of blood cells via bone-marrow trans-
plant. Intravascular transplant methods have also been explored
for cell-replacement therapy involving skeletal muscle precur-
sors andmesenchymal stem cells, although inmany cases these
cell populations have exhibited limited efficiency for engraftment
in target organs (reviewed in Peault et al., 2007). The study of
in vivo stem cell homing andmigration has taught us that traffick-
ing patterns differ between stem cell lineages, and are strongly
influenced by the normal interactions between these cells and
their niches during development and in the adult. Thus, stem
cells should not be considered as broadly acting ‘‘heat-seeking
missiles’’ that are capable of specifically searching out and tar-
geting diseased or dysfunctional tissues. Nevertheless, a deeper
knowledge of the natural migratory properties of stem cells and
of the ways in which stem cell trafficking patterns can be manip-
ulated may reveal new ways to exploit their unique properties.
For example, because stem cells possess extensive self-
renewal capacity, they represent particularly attractive delivery
vehicles for drug or gene therapy because they would allow
long-term production of disease modulators and ongoing re-
placement of missing or defective gene products. In fact, recent
studies in a mouse xenotransplant model of human glioma pro-
vide some support for this notion. In these studies, intracranially
injected mouse neural precursor cells showed the surprising
ability to migrate from the contralateral hemisphere of the brain
to primary and secondary glioma foci. The targeted migration
of these cells was exploited to deliver cytotoxic tumor therapy,
thereby reducing tumor growth (Shah et al., 2005). The analo-
gous capacity of hematopoietic and muscle stem cells to
home through the circulation or to navigate within the tissue
interstitium to target distinct niches within the body raises the in-
triguing possibility that these cells may likewise be useful as drug
or gene-delivery vectors.
Conclusions and Perspective
Just how critical is interstitial migration and blood-to-tissue hom-
ing for the specification of stem cells in the embryo, for the re-
placement and repair of adult tissues, and for the maintenance
and spread of tumor-propagating cancer stem cells? On a prac-
tical level, the establishment of new cell lineages and coordina-
tion of organogenesis during development requires mechanical
separation of precursors from surrounding cells. For example,
to seed muscle formation and satellite cell pools at distant sites
throughout the body, embryonic myogenic precursors must first
delaminate from their original site of specification in the dermo-
myotome (Buckingham et al., 2003) and migrate to new loca-
tions. Relocation to a new environment also may permit nascent
or maturing stem cells to receive appropriate induction signals or
may shield them from inappropriate signals. For example, mouse
PGC precursors make a brief detour to extraembryonic regions,
and embryological studies demonstrate that this sojourn is re-
quired for establishment of the PGC lineage (Snow, 1981). Re-
cent work proposes a molecular mechanism for this shielding,
demonstrating that induction of the transcriptional repressor
Blimp1 in these extraembryonic mouse PGCs prevents the ex-
pression of genes that would otherwise activate a somatic cell
differentiation program (Ohinata et al., 2005). The next important
question to answer will be how the extraembryonic niche regu-
lates Blimp1 in PGCs to prevent the activation of default somatic
differentiation programs. In any event, such observations arguethat the development of some stem cells cannot be completed
in a single niche and that signals gleaned from multiple microen-
vironments must be integrated over time. Recent advances in
stem cell isolation and visualization in situ and in forward genet-
ics will facilitate the identification and study of mutant flies, fish,
and mice with defects in anatomically discrete aspects of stem
cell migration. These tools will enable formal testing in multiple
tissue systems of the relationship between stem cell function
and stem cell migration and homing during development.
Is there something unique about the migration and homing of
stem cells? Extensive migration during development and in adult
life is a property of many cells, including stem cells, progenitors,
and differentiated cells. In fact, not one of the molecular mecha-
nisms discussed here operates exclusively in stem cells; on the
contrary, stem cells appear to home andmigrate bymechanisms
common to many itinerant cells, including mature leukocytes
and neural crest and endothelial cells. If in fact there are no par-
ticular molecules that function exclusively in the adhesion,
movement, and navigation of stem cells, then perhaps the spe-
cific routes traveled by stem cells are patterned and timed
more subtly, through the expression of particular combinations
of trafficking molecules or by integration of migratory cues with
other stem cell signaling pathways. Nonetheless, while stem
cell trafficking may not invoke molecular mechanisms unique
to stem cells, our consideration of the movement of HSCs,
PGCs, and satellite cells does reveal intriguing commonalities,
including utilization of the SDF-1a/CXCR4 chemotaxis pathway
and linkage of stem cell proliferation and movement, which ap-
pear to be shared in developing and adult tissues by all of these
migrating stem cell populations.
Among the examples we have considered, chemotactic sig-
naling via the SDF-1a/CXCR4 axis stands alone as a broadly
conserved migration mechanism that acts in stem cell move-
ments in multiple tissues in both the embryo and adult. During
development, SDF-1a/CXCR4 signals direct the homing of fetal
mouse HSCs to the liver and marrow (Ma et al., 1998; Nagasawa
et al., 1996; Zou et al., 1998), guide fish andmouse PGCs toward
the gonadal ridge (Ara et al., 2003; Molyneaux et al., 2003), and
help to target mouse myogenic precursor cells as they migrate
from the dermomyotome (Vasyutina et al., 2005). In the adult,
SDF-1a and CXCR4 regulate the mobilization of mouse and hu-
man HSCs into the peripheral blood as well as their re-entry into
themarrow (Broxmeyer et al., 2005; Peled et al., 1999; Sugiyama
et al., 2006), and facilitate skeletal muscle regeneration (De
Paepe et al., 2004; Ratajczak et al., 2003). This chemotactic
pathway also functions in the dissemination of tumor-forming
cells in a large number of metastatic cancers (Balkwill, 2004).
The remarkable ubiquity of SDF-1a/CXCR4 signaling in regulat-
ing a diverse array of stem cells in a diversity of contexts certainly
begs the question of whether this pathway may have some
unique or stem cell-specific functions. Yet SDF-1a/CXCR4 sig-
nals also regulate several processes apparently unrelated to
stem cell activity, including the normal trafficking of lymphocyte
precursors and mature hematopoietic cells, migration of cere-
bellar neurons, and cardiogenesis (reviewed in Burger and
Kipps, 2006). In any event, our understanding of this pathway
in stem cell regulation is as yet incomplete; for example, it re-
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receptor for SDF-1a, CXCR7 likewise regulates multiple stem
cell types (although a lack of overt hematopoietic phenotypes
in mice conditionally lacking this receptor argues against a cru-
cial role for CXCR7 in HSCs (Sierro et al., 2007). Further charac-
terization of both the upstream and downstream components of
the SDF-1a/CXCR4 pathway may highlight important differ-
ences between cell lineages or identify aspects unique to stem
cells. A broader understanding of SDF-1a/CXCR4 molecular
regulation and response circuitry may shed new light on how
this particular chemokine pathway may have become so impor-
tant for the trafficking of multiple types of stem cells in develop-
ment, disease, and regeneration.
In addition to frequent use of SDF-1a/CXCR4 signaling, a sec-
ond common aspect of the movement of stem cells in the
embryo and adult appears to be coordination of migration with
regulation of stem cell numbers (Hawke and Garry, 2001; Morri-
son et al., 1997; Zammit et al., 2004). For example, during devel-
opment, HSCs switch from a state of rapid proliferation to a state
of relative quiescence soon after homing to the bone marrow
(Bowie et al., 2006). For PGCs, the connection between prolifer-
ation andmigration is implied by the growing list of genes that act
in both processes: c-Kit/KitL (Runyan et al., 2006), SDF-1a/
CXCR4 (Ara et al., 2003; Molyneaux et al., 2003), and zebrafish
Dead end (Kunwar et al., 2006). Misregulation of proliferation
or migration of any of these stem cell typesmay have dire biolog-
ical consequences, such as anemia, myopathy, infertility, and
cancer. For example, in the germline, aberrant PGC regulation
can give rise to extragonadal tumors derived from vagrant
PGCs (Runyan et al., 2006), and the prevention of germline can-
cers necessitates additional control of cell survival during the
migration of PGCs. In mice, PGCs that fail to migrate not only
fail to proliferate but are actively deleted by apoptosis pathways
involving the proapoptosis protein Bax (Runyan et al., 2006) or
other mechanisms such as theWunen pathway in flies (reviewed
in Kunwar et al., 2006). In the adult, direct analysis of HSCmove-
ment in vivo corroborates a mechanistic link between HSC
cell-cycle progression and migration. HSC-mobilizing agents
often simultaneously enhance stem cell proliferation and migra-
tion into the blood (Morrison et al., 1997). Furthermore, recent
analysis of mice lacking the transcription factor Egr1 demon-
strates a direct molecular link between HSC proliferation and in
vivo localization, both of which are perturbed in Egr1-deficient
HSCs (I.M. Min and A.J.W., unpublished data). The reverse pro-
cesses of homing and bone-marrow engraftment of transplanted
HSCs also appear to be linked to cell-cycle status, as dividing
HSCs exhibit compromised bone-marrow homing and long-
term hematopoietic reconstituting capacities (Bowie et al.,
2006; Passegue et al., 2005). Finally, in skeletalmuscle, activation
of satellite cells followingmuscle injury induces both their prolifer-
ation and their migration to damaged regions of the same or
adjacent muscle fibers, whereas, conversely, re-entry into
the satellite cell niche is associated with a return to mitotic quies-
cence (Hawke and Garry, 2001; Zammit et al., 2004). These
examples from several different systems reveal a coordination
of stem cell proliferation and migration, which may enable ‘‘sys-
tem-wide’’ maintenance of appropriate stem cell numbers and
limit stem cell expansion to only the appropriate locations and
contexts.626 Cell 132, 612–630, February 22, 2008 ª2008 Elsevier Inc.Further perspective on how and why stem cells migrate will
likely come from studies in a diversity of model organisms. As
discussed here, many insights have been gleaned from both
vertebrate and nonvertebrate systems. In addition, stem cell
movement both in development and in adult tissues duringmain-
tenance and repair appears to be evolutionarily conserved. In-
deed, ascidians—a phylogenetic intermediate between inverte-
brates and vertebrates—offer a unique perspective on stem
cell homing. Colonial ascidians such as B. schlosseri are com-
prised of successively regenerating clonal individuals and main-
tain lineages of stem cells to build bodies and to make gametes.
Although their origins during the organism’s adult life remain
opaque, these somatic stem cells and germline stem cells mi-
grate from old to new bodies to carry out normal colony regener-
ation. Like other homing stem cells, they transit through the
vasculature and may reside in multiple niches; however, B.
schlosseri stem cells also invade and colonize the bodies and
gonads of other genetically distinct colonies (Laird et al., 2005).
Thus, in this example, stem cell homing provides a mechanism
not only for homeostatic regeneration but also for evolutionary
competitiveness by enabling parasitization of the gonads of
others to expand reproductive capacity. Although little is cur-
rently known regarding the molecular mechanisms that control
stem cell homing and engraftment in B. schlosseri, ongoing ge-
nomic analyses have identified homologs of many key mamma-
lian adhesion proteins including selectins, integrins, ICAMs, and
NCAMs (A. De Tomaso, personal communication), suggesting
evolutionary conservation of themediators of stem cell migration
and engraftment in this organism. Recent studies suggest that
stem cell competition also occurs in a more commonly studied
model organism, the fruit fly Drosophila melanogaster, where it
appears that a major determinant of the ‘‘competitiveness’’ of
germline stem cells (GSCs)—that is, their success in being main-
tained in the ovary—relates to their expression of cadherin re-
ceptors, which allow them to maintain contact with their niche.
Fly GSCs that express higher levels of cadherin adhere better
to supportive niche cells (called cap cells), as indicated by an ex-
panded area of contact between cadherinhi GSCs and cap cells.
Indeed, cadherinhi GSCs can actually expel less competitive
cadherinlo GSCs from the niche and replace them via symmetric
self-renewing division (Jin et al., 2008). Whether similar adhe-
sion-based competition helps to determine ‘‘winners’’ and
‘‘losers’’ in the B. schlosseri gonad will be an important question
to address. Elucidating the molecular basis of what appears to
be a high-stakes stem cell homing competition in colonial ascid-
ians as well as fly ovaries will likely provide unique insights into
how and why stem cells home.
What do we gain from understanding stem cell migration? The
migration and homing of adult HSCs has been tremendously
useful in the clinical application of these cells in bone-marrow
transplantation. Revealing the importance of HSC movement
and the role of distinct niches in specifying their function during
development and in adulthood will likely enable their improved
therapeutic application. The study of stem cell migration may
also catalyze ongoing efforts to derive specialized precursor
cells from pluripotent embryonic stem cells or induced pluripo-
tent stem (iPS) cells, particularly as sequential exposure to
multiple distinct microenvironments during stem cell homing or
interstitial migration appears to be commonly required for appro-
priate stem cell specification and maturation. A deeper under-
standing of the migratory activity of PGCs, HSCs, satellite cells,
and other stem and progenitor cell populations will likely accel-
erate progress towards exploiting these cells for regenerative
medicine. Finally, an improved capacity to control stem cell
migration will have important implications for drug delivery and
anticancer therapies, perhaps enabling highly specific interven-
tions to promote endogenous function or to ablate cancer stem
cells. Through continuing comparative analysis of stem cell
movement in a variety of model systems and organs, we un-
doubtedly will uncover additional critical mechanisms governing
the decisions of these dynamic cells tomigrate or to home to dis-
tant sites in the body, and these insights will be translated into
new tools for regenerative medicine and anticancer therapy.
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